JP2024526820A5 - - Google Patents
Info
- Publication number
- JP2024526820A5 JP2024526820A5 JP2024502611A JP2024502611A JP2024526820A5 JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5 JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024502611 A JP2024502611 A JP 2024502611A JP 2024526820 A5 JP2024526820 A5 JP 2024526820A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- fusion protein
- composition according
- actrii
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163223265P | 2021-07-19 | 2021-07-19 | |
| US63/223,265 | 2021-07-19 | ||
| PCT/US2022/037479 WO2023003815A1 (en) | 2021-07-19 | 2022-07-18 | Actrii proteins and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024526820A JP2024526820A (ja) | 2024-07-19 |
| JP2024526820A5 true JP2024526820A5 (cg-RX-API-DMAC7.html) | 2025-07-17 |
Family
ID=84979535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024502611A Pending JP2024526820A (ja) | 2021-07-19 | 2022-07-18 | Actriiタンパク質およびその用途 |
Country Status (18)
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4121088A4 (en) | 2020-03-20 | 2024-07-03 | Keros Therapeutics, Inc. | Methods of using activin receptor type iib variants |
| EP4121078A4 (en) | 2020-03-20 | 2024-08-14 | Keros Therapeutics, Inc. | ACTIVIN RECEPTOR TYPE II CHIMERAS AND METHODS OF USE THEREOF |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI745271B (zh) * | 2014-05-19 | 2021-11-11 | 美商西建公司 | 全身紅斑性狼瘡之治療 |
| WO2016146573A1 (en) * | 2015-03-13 | 2016-09-22 | Repoceuticals Aps | Melatonin for preventing and treating radiation cystitis |
| JP7072507B2 (ja) * | 2015-11-23 | 2022-05-20 | アクセルロン ファーマ インコーポレイテッド | 眼の障害を処置するための方法 |
| PL4218804T3 (pl) * | 2016-06-13 | 2026-05-25 | Scholar Rock, Inc. | Stosowanie inhibitorów miostatyny i terapii skojarzonych |
| AU2017296040C1 (en) * | 2016-07-15 | 2023-06-22 | Acceleron Pharma Inc. | Compositions and methods for treating pulmonary hypertension |
-
2022
- 2022-07-18 KR KR1020247005282A patent/KR20240049857A/ko active Pending
- 2022-07-18 AU AU2022316103A patent/AU2022316103A1/en active Pending
- 2022-07-18 IL IL310141A patent/IL310141A/en unknown
- 2022-07-18 JP JP2024502611A patent/JP2024526820A/ja active Pending
- 2022-07-18 WO PCT/US2022/037479 patent/WO2023003815A1/en not_active Ceased
- 2022-07-18 CA CA3225613A patent/CA3225613A1/en active Pending
- 2022-07-18 PE PE2024000111A patent/PE20240777A1/es unknown
- 2022-07-18 US US18/580,425 patent/US20240327494A1/en active Pending
- 2022-07-18 CR CR20240061A patent/CR20240061A/es unknown
- 2022-07-18 EP EP22846466.5A patent/EP4373577A4/en active Pending
- 2022-07-18 CN CN202280060109.7A patent/CN117957014A/zh active Pending
- 2022-07-18 GE GEAP202416461A patent/GEP20267899B/en unknown
- 2022-07-18 MX MX2024000829A patent/MX2024000829A/es unknown
-
2024
- 2024-01-17 CL CL2024000151A patent/CL2024000151A1/es unknown
- 2024-01-18 DO DO2024000016A patent/DOP2024000016A/es unknown
- 2024-01-18 JO JOJO/P/2024/0010A patent/JOP20240010A1/ar unknown
- 2024-02-14 CO CONC2024/0001551A patent/CO2024001551A2/es unknown
- 2024-02-19 EC ECSENADI202412819A patent/ECSP24012819A/es unknown
-
2026
- 2026-04-17 DO DO2026000113A patent/DOP2026000113A/es unknown